Creating a tumor-resistant microenvironment: Cell-mediated delivery of TNFα completely prevents breast cancer tumor formation in vivo
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Creating a tumor-resistant microenvironment: Cell-mediated delivery of TNFα completely prevents breast cancer tumor formation in vivo
Authors
Keywords
-
Journal
CELL CYCLE
Volume 12, Issue 3, Pages 480-490
Publisher
Informa UK Limited
Online
2013-01-29
DOI
10.4161/cc.23370
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic use of tumor necrosis factor alpha as an anticancer agent
- (2015) Nicholas J. Roberts et al. Oncotarget
- NF- B Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
- (2012) R. Uchibori et al. CANCER RESEARCH
- Energy transfer in "parasitic" cancer metabolism
- (2012) Ubaldo E. Martinez-Outschoorn et al. CELL CYCLE
- Metabolic reprogramming and two-compartment tumor metabolism
- (2012) Barbara Chiavarina et al. CELL CYCLE
- CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, “fueling” tumor growth via paracrine interactions, without an increase in neo-angiogenesis
- (2012) Claudia Capparelli et al. CELL CYCLE
- Power Surge: Supporting Cells “Fuel” Cancer Cell Mitochondria
- (2012) Ubaldo E. Martinez-Outschoorn et al. Cell Metabolism
- Preactivation of Human MSCs with TNF-α Enhances Tumor-Suppressive Activity
- (2012) Ryang Hwa Lee et al. Cell Stem Cell
- Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands
- (2012) Stephan Munich et al. OncoImmunology
- Caveolin-1 and Cancer Metabolism in the Tumor Microenvironment: Markers, Models, and Mechanisms
- (2011) Federica Sotgia et al. Annual Review of Pathology-Mechanisms of Disease
- Warburg Meets Autophagy: Cancer-Associated Fibroblasts Accelerate Tumor Growth and Metastasis via Oxidative Stress, Mitophagy, and Aerobic Glycolysis
- (2011) Stephanos Pavlides et al. ANTIOXIDANTS & REDOX SIGNALING
- Observational studies on the risk of cancer associated with tumor necrosis factor inhibitors in rheumatoid arthritis: A review of their methodologies and results
- (2011) D. H. Solomon et al. ARTHRITIS AND RHEUMATISM
- Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey
- (2011) B. B. Aggarwal et al. BLOOD
- Accelerated aging in the tumor microenvironment
- (2011) Michael P Lisanti et al. CELL CYCLE
- Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis
- (2011) Michael P Lisanti et al. CELL CYCLE
- Regression of Hodgkin Lymphoma After Discontinuation of a Tumor Necrosis Factor Inhibitor for Crohn's Disease: A Case Report and Review of the Literature
- (2011) Ryan D. Cassaday et al. Clinical Lymphoma Myeloma & Leukemia
- Does Anti-Tumor Necrosis Factor- Therapy Affect Risk of Serious Infection and Cancer in Patients with Rheumatoid Arthritis?: A Review of Longterm Data
- (2011) E. C. KEYSTONE JOURNAL OF RHEUMATOLOGY
- The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: A systematic review and meta-analysis of randomized controlled trials
- (2011) Erica D. Dommasch et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Understanding the "lethal" drivers of tumor-stroma co-evolution
- (2010) Michael P. Lisanti et al. CANCER BIOLOGY & THERAPY
- Tumor necrosis factor and cancer, buddies or foes?
- (2009) Xia Wang et al. ACTA PHARMACOLOGICA SINICA
- Tumor necrosis factor-related apoptosis-inducing ligand and the regulation of hematopoiesis
- (2009) Paola Secchiero et al. CURRENT OPINION IN HEMATOLOGY
- Metastasis Suppressor Function of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-R in Mice: Implications for TRAIL-Based Therapy in Humans?
- (2008) A. Grosse-Wilde et al. CANCER RESEARCH
- Tumor Necrosis Factor: Renaissance as a Cancer Therapeutic?
- (2008) D. Daniel et al. CURRENT CANCER DRUG TARGETS
- Tumor necrosis factor-mediated interactions between inflammatory response and tumor vascular bed
- (2008) Timo L. M. ten Hagen et al. IMMUNOLOGICAL REVIEWS
- Ligand-Based Targeting of Apoptosis in Cancer: The Potential of Recombinant Human Apoptosis Ligand 2/Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (rhApo2L/TRAIL)
- (2008) Avi Ashkenazi et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started